VentriPoint Diagnostics (TSE:VPT) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Ventripoint Diagnostics has successfully closed debt settlement agreements by issuing 128,900 common shares to settle $19,335 of debt owed to a former director and their holding company. This strategic move allows Ventripoint to conserve cash for future business development. The shares issued as part of this transaction are subject to approval by the TSX Venture Exchange.
For further insights into TSE:VPT stock, check out TipRanks’ Stock Analysis page.